Thyroxine antibody | BGN/0980/322 (T4:1-32.2)
Mouse anti thyroxine antibody, clone BGN/0980/322 recognizes thyroxine, a form of thyroid hormone secreted by the follicular cells of the thyroid gland. Mouse anti thyroxine antibody, clone BGN/0980/322 does not cross react with either rT3 or T3.
- Target Species
- Species Cross-Reactivity
Target Species Cross Reactivity Mouse flounder (Paralichthys olivaceus)
- N.B. Antibody reactivity and working conditions may vary between species.
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein G
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.09% Sodium Azide (NaN3)
- Carrier Free
- Thyroxine conjugated to Bovine Serum Albumin.
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted.
Avoid repeated freezing and thawing as this may denature the antibody.
Should this product contain a precipitate we recommend microcentrifugation before use.
- 18 months from date of despatch.
- For research purposes only
Applications of Thyroxine antibody
|Application Name||Verified||Min Dilution||Max Dilution|
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2019 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
References for Thyroxine antibody
Carre, A. et al. (2011) Hes1 is required for appropriate morphogenesis and differentiation during mouse thyroid gland development.
PLoS One. 6: e16752.
Washio, Y. et al. (2015) Exposure to oxidative by-products during metamorphosis affects pigmentation patterns in flounder, Paralichthys olivaceus.
Aquaculture 435: 318-27.